United Kingdom: Intellectual Property

Article 50 of the EU AI Act introduces sweeping transparency obligations for AI providers and deployers, requiring disclosure of AI interactions, marking of AI-generated content, and labeling of deepfakes. These rules carry significant commercial and IP implications for businesses using AI to create marketing materials, synthetic influencers, and other valuable assets.

Summer festivals create memorable experiences through music, food, and culture, but behind the excitement lies a complex portfolio of intellectual property assets. From trademark protection of festival names to copyright management of performances and merchandise licensing, these legal frameworks help organizers build lasting brands that generate value long after the final encore.

The dispute between Shein and Temu has escalated into one of the most significant intellectual property battles in modern retail, with a recent UK High Court judgment providing crucial clarity on marketplace operator liability and hosting defences.

University intellectual property commercialisation presents complex challenges around ownership, protection, and value realisation. This analysis examines how UK universities navigate the journey from academic research to market-ready ventures, exploring spinout formation, licensing strategies, and the critical role of patent protection in life sciences innovation.

EU design law has been updated from 1 July 2026, with reforms aimed at making design protection more suited to digital products and modern methods of creation and copying. The changes include dynamic representations like CAD files and animations, expanded protection for GUIs and non-physical items, and strengthened enforcement against counterfeiting and 3D printing.

Summer festivals create memorable experiences through music, food, and culture, but behind the excitement lies a complex portfolio of intellectual property assets. From trademark protection of festival names to copyright management of performances and merchandise licensing, these legal frameworks help organizers build lasting brands that generate value long after the final encore.

University intellectual property commercialisation presents complex challenges around ownership, protection, and value realisation. This analysis examines how UK universities navigate the journey from academic research to market-ready ventures, exploring spinout formation, licensing strategies, and the critical role of patent protection in life sciences innovation.

Claims can contain alternatives, e.g. “…wherein the communication link is a wired link or a wireless link…”. T 1186/24, a recent decision from the European Patent Office’s Boards of Appeal, reminds us that the requirements of the European Patent Convention must be met by all alternatives within a claim.

Pharmaceutical companies are exploring microgravity environments to develop improved drug formulations and discover novel crystal forms of medicines. From monoclonal antibody treatments...

Imagine an invention machine that is capable of analysing all published human scientific knowledge and then extrapolating forward. If this invention machine were then to publish its own predictions of, say, future materials, hypothetical drug compounds, or improved cell-based therapies, could this prevent future innovations from being patented?

Chemistry start-ups face critical decisions when building patent portfolios that can determine their commercial success. From timing patent applications before public disclosures...

The Court of Appeal has clarified the meaning of "public domain" in non-disclosure agreements, holding that professionally drafted NDAs use this term in its established legal sense to mean information generally accessible to the public. The decision provides crucial guidance on how courts will interpret confidentiality exceptions and what level of disclosure actually strips information of its protected status.